Last updated: 25 April 2024 at 6:20pm EST

Douglas Michels Net Worth




The estimated Net Worth of Douglas A Michels is at least $35.4 Million dollars as of 1 September 2020. Mr. Michels owns over 50,000 units of West Pharmaceutical Services stock worth over $33,258,500 and over the last 20 years he sold WST stock worth over $1,780,634. In addition, he makes $328,834 as Independent Director at West Pharmaceutical Services.

Mr. Michels WST stock SEC Form 4 insiders trading

Douglas has made over 19 trades of the West Pharmaceutical Services stock since 2012, according to the Form 4 filled with the SEC. Most recently he bought 50,000 units of WST stock worth $48,000 on 1 September 2020.

The largest trade he's ever made was exercising 361,216 units of West Pharmaceutical Services stock on 5 May 2017 worth over $2,463,493. On average, Douglas trades about 13,357 units every 23 days since 2004. As of 1 September 2020 he still owns at least 110,000 units of West Pharmaceutical Services stock.

You can see the complete history of Mr. Michels stock trades at the bottom of the page.





Douglas Michels biography

Douglas A. Michels serves as Independent Director of the Company. Mr. Michels retired from OraSure Technologies, Inc.—a leader in the development, manufacture and distribution of oral fluid diagnostic and collection devices and other technologies designed to detect or diagnose critical medical conditions—in March 2018, after serving as President and CEO, as well as a member of the Board of Directors, since June 2004. Prior to joining OraSure, Mr. Michels served as Group Vice President, Global Marketing of Ortho-Clinical Diagnostics, President of Ortho-Clinical Diagnostics International, and President of Johnson & Johnson Healthcare Systems, Inc. In February 2010, Mr. Michels was appointed to the Presidential Advisory Council on HIV/AIDS. He previously served on the Board of the National Blood Foundation, the Board of the National Committee for Quality Health Care and the Coalition to Protect America's Health Care. He now serves on the boards of Tyme Technologies Inc. and St. Luke's University Health Network.

What is the salary of Douglas Michels?

As the Independent Director of West Pharmaceutical Services, the total compensation of Douglas Michels at West Pharmaceutical Services is $328,834. There are 11 executives at West Pharmaceutical Services getting paid more, with Eric Green having the highest compensation of $6,533,690.



How old is Douglas Michels?

Douglas Michels is 63, he's been the Independent Director of West Pharmaceutical Services since 2011. There are 5 older and 21 younger executives at West Pharmaceutical Services. The oldest executive at West Pharmaceutical Services, Inc. is Patrick Zenner, 73, who is the Independent Chairman of the Board.

What's Douglas Michels's mailing address?

Douglas's mailing address filed with the SEC is 530 HERMAN O. WEST DRIVE, , EXTON, PA, 19341.

Insiders trading at West Pharmaceutical Services

Over the last 19 years, insiders at West Pharmaceutical Services have traded over $32,829,857 worth of West Pharmaceutical Services stock and bought 19,924 units worth $1,139,950 . The most active insiders traders include Robert F Friel, Paolo Pucci, and Douglas A Michels. On average, West Pharmaceutical Services executives and independent directors trade stock every 40 days with the average trade being worth of $4,786,805. The most recent stock trade was executed by Charles Witherspoon on 19 August 2024, trading 1,029 units of WST stock currently worth $308,700.



What does West Pharmaceutical Services do?

west works side-by-side with healthcare partners from concept to the patient, designing and manufacturing packaging and delivery systems that promote efficiency, reliability and safety. west leads the way with cutting-edge technologies and quality systems, a thorough understanding of global regulatory compliance, and an unmatched knowledge of relevant pharmaceutical product testing, development and packaging. west supports customers from sales, manufacturing, and research and development locations in north and south america, europe, asia and australia.



Complete history of Mr. Michels stock trades at Orasure Technologies, West Pharmaceutical Services, and Tyme Technologies Inc

Insider
Trans.
Transaction
Total value
Douglas A Michels
Director
Buy $48,000
1 Sep 2020
Douglas A Michels
Director
Buy $65,200
14 Feb 2019
Douglas A Michels
President and CEO
Sale $527,229
4 Oct 2017
Douglas A Michels
President and CEO
Sale $563,750
29 Sep 2017
Douglas A Michels
President and CEO
Option $3,102,487
27 Jun 2017
Douglas A Michels
President and CEO
Option $1,216,840
9 May 2017
Douglas A Michels
President and CEO
Option $2,463,493
5 May 2017
Douglas A Michels
President and CEO
Option $786,955
9 Feb 2017
Douglas A Michels
President and CEO
Option $578,875
13 Dec 2016
Douglas A Michels
President and CEO
Option $197,817
9 Dec 2016
Douglas A Michels
President and CEO
Sale $278,655
23 Nov 2016
Douglas A Michels
President and CEO
Sale $205,500
26 Sep 2016
Douglas A Michels
President and CEO
Sale $205,500
26 Sep 2016
Douglas A Michels
President and CEO
Option $70,543
3 Dec 2014
Douglas A Michels
President and CEO
Option $363,285
9 Jul 2012
Douglas A Michels
President and CEO
Option $466,200
6 Jul 2012
Douglas A Michels
President and CEO
Option $1,631,863
30 Jun 2012
Douglas A Michels
President and CEO
Option $371,266
16 May 2012
Douglas A Michels
President and CEO
Option $582,750
30 Mar 2012


West Pharmaceutical Services executives and stock owners

West Pharmaceutical Services executives and other stock owners filed with the SEC include: